NIH – Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R01 and R21)

12/01/2018 11:58

Objetivo: To encourage research grant applications to: assess and describe the current state of oral anticancer medication utilization, delivery, and adherence; identify structural, systemic, and psychosocial barriers to adherence; and develop models and strategies to improve safe and effective delivery of these agents so that clinical outcomes are optimized.

Inscrições: até 16 de fevereiro de 2018

Mais informações no R01 e R21.

Tags: BolsaExteriorNIH